BioE3 (Biotechnology for Economy, Environment and Employment) is India’s national biomanufacturing policy. The Union Cabinet approved it in August 2024, and the Department of Biotechnology (DBT) runs it. It backs six sectors, from bio-based chemicals to precision biotherapeutics, through research funding and shared facilities. Each sector needs a different kind of building: fermentation pilot plants, GMP cleanrooms, food-grade suites or greenhouses.
What is the BioE3 policy?
The Cabinet approved BioE3 on 24 August 2024 to build what it calls “high performance biomanufacturing”: using biology (microbes, cells, enzymes) to make medicines, materials, food and farm inputs at industrial scale. The policy has three main levers:
Research and startup funding across six thematic sectors
BioEnablers: a national network of shared Biomanufacturing Hubs, Bio-AI Hubs and Biofoundries
Centre-state partnerships, including dedicated BioE3 cells in state governments
A biofoundry is an automated lab that designs, builds and tests engineered organisms quickly. It speeds up the step before scale-up. A biomanufacturing hub provides shared pilot and pre-commercial production capacity.
What are the six BioE3 sectors?
The Cabinet decision lists six thematic sectors:
High-value bio-based chemicals, biopolymers and enzymes
Smart proteins and functional foods
Precision biotherapeutics
Climate-resilient agriculture
Carbon capture and its utilisation
Marine and space research
What progress has BioE3 made by 2026?
In April 2026, the Minister of State for Science and Technology told the Rajya Sabha that the BioEnablers network is being rolled out as a public-private effort. It is meant to give startups, academic labs and SMEs shared pilot and pre-commercial infrastructure, so they can scale up without heavy upfront capital.
A July 2026 parliamentary reply reported further progress. [VERIFY BEFORE PUBLISHING against the PIB release:]
More than 270 projects recommended for funding from over 2,000 proposals
17 facilities funded as biofoundries and biomanufacturing hubs
15 Bio-AI Hubs recommended
A memorandum of understanding with the Ministry of Electronics and IT (MeitY) for AI computing access
The direction is clear: public facilities will cover early scale-up. Companies that move past pilot scale will still need their own space, and that is where most private infrastructure demand will come from
| BioE3 Sector | Typical Products | Facility Type Needed | Key Building Requirements | Adjacent Industries |
|---|---|---|---|---|
| Bio-based chemicals, biopolymers and enzymes | Industrial enzymes, bio-based chemicals, biodegradable plastics | Fermentation pilot plant with downstream processing | Tall bays for fermenters, steam and cooling water, solvent handling, effluent treatment | Materials and chemicals; clean and environmental tech |
| Smart proteins and functional foods | Precision-fermented proteins, probiotics, nutraceuticals, cultivated meat | Food-grade fermentation or cell culture suite | Hygienic design, food-safety-ready utilities, segregated allergen handling | FMCG and consumer science |
| Precision biotherapeutics | Antibodies, cell and gene therapies, mRNA | GMP cleanrooms, BSL-2 labs, cryostorage | Classified cleanrooms, pressure cascades, validated HVAC and water, qualification | Biomanufacturing and advanced therapeutics |
| Climate-resilient agriculture | Biofertilisers, biopesticides, gene-edited seeds | Microbial fermentation plus greenhouse or growth-chamber labs | Controlled growth environments, containment for regulated organisms, field-trial links | Agri and animal sciences |
| Carbon capture and utilisation | Microbial or algal conversion of CO₂ into fuels and chemicals | Pilot reactors, photobioreactors, gas-handling bays | Gas supply and detection, outdoor or high-bay pilot areas, process safety | Clean and environmental tech |
| Marine and space research | Marine bioresources, biomanufacturing in space | Specialised research labs | Seawater handling, mission-specific test rigs | Mostly public research institutions for now |
What facilities do biomanufacturing startups need, stage by stage?
Discovery lab. A wet lab with basic microbiology or cell culture, often in an incubator.
Strain and process development. Biofoundry access (public or private) plus bench-top fermenters.
Pilot scale. Pilot fermenters with downstream processing to prove the process at scale. Shared BioE3 hubs are aimed at this stage.
Demonstration or first commercial batch. A dedicated suite with the full utilities, effluent treatment and approvals your product category needs.
Commercial manufacturing. A full facility, leased, built-to-suit or owned.
Each step up the ladder usually needs a different space. Planning the jump from stage 3 to stage 4 early saves the most time.
What should you check before choosing a pilot-scale facility?
Does the building have enough clear height for your largest vessel?
Are steam, chilled water and compressed air available, and at what capacity?
Can the effluent treatment plant handle your broth, solvents or biological waste?
What biosafety level and containment are permitted?
Is the space food-grade, GMP-grade or industrial? Does that match your product?
Can you expand on the same site from pilot to commercial scale?
Who handles pollution control and other approvals?
Where do private campuses fit alongside public BioE3 hubs?
Public hubs are best for early, shared, low-cost access. Private science campuses suit companies that need dedicated space, control over their own schedule, or a path to commercial scale on one site. Many companies will use both: a public biofoundry for strain work and a private suite for production.
NQF Hubs (NXT QST FWD) provides research and pilot labs and manufacturing facilities on its Solutions page, with GMP-ready biomanufacturing modules and build-to-suit options. Its sector focus is widening from life sciences into agri, consumer science, materials and clean tech, which lines up with several BioE3 sectors.
[CONFIRM: pilot fermentation capacity available today, whether food-grade or agri-biotech space is offered, permitted biosafety levels, and which BioE3 sectors NQF can serve now vs later.] For more detail on biomanufacturing facilities in India and how long a lab or cleanroom build-out takes, see our related guides. [EDITOR: confirm Post 4 URL once live.]
Frequently asked questions
What is the BioE3 policy?
BioE3 (Biotechnology for Economy, Environment and Employment) is India’s biomanufacturing policy, approved by the Union Cabinet in August 2024 and run by the Department of Biotechnology. It funds R&D in six sectors and builds shared Biomanufacturing Hubs, Bio-AI Hubs and Biofoundries.
What are the six sectors of BioE3?
Bio-based chemicals, biopolymers and enzymes; smart proteins and functional foods; precision biotherapeutics; climate-resilient agriculture; carbon capture and utilisation; and marine and space research.
What facilities do biomanufacturing startups need in India?
Most start in a wet lab, move to biofoundry and bench-scale fermentation, then need pilot-scale fermentation with downstream processing. After pilot scale, they need a dedicated facility that matches their product’s regulatory grade, whether GMP, food-grade or industrial.
What is a biofoundry?
A biofoundry is an automated facility that designs, builds and tests engineered organisms rapidly using robotics and data tools. Under BioE3, biofoundries are part of a national network of shared infrastructure for startups and researchers.
Can startups use BioE3 facilities instead of leasing space?
For early and pilot work, often yes, since shared BioE3 hubs aim to reduce upfront capital needs. Companies that need dedicated capacity, confidentiality or commercial-scale production usually move into their own leased or built-to-suit facilities.
Call to action
Building a biomanufacturing company? Talk to NQF Hubs about pilot and production space that matches your sector and stage, or request the campus brochure. [CTA LINK]
3. External sources cited
1. PM India / PIB — “Cabinet approves BioE3 (Biotechnology for Economy, Environment and Employment) Policy for Fostering High Performance Biomanufacturing” (24 Aug 2024). https://www.pmindia.gov.in/en/news_updates/cabinet-approves-bioe3-biotechnology-for-economy-environment-and-employment-policy-for-fostering-high-performance-biomanufacturing/
2. Department of Biotechnology, PIB Chennai — Press release on BioE3 (6 Sep 2024). https://dbtindia.gov.in/sites/default/files/Press%20Release_Varthalap_0.pdf
3. Indian Pharma Post — “BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech” (3 Apr 2026), reporting the 2 April 2026 Rajya Sabha reply. https://www.indianpharmapost.com/policy/lite/bioe3-policy-accelerates-indias-biomanufacturing-ambitions-with-biofoundries-ai-hubs-space-biotech-19541
4. [VERIFY] PIB release of the July 2026 parliamentary reply on BioE3 implementation. The document notes that the figures were found only on an exam-prep summary site, so the official PIB URL needs to be added before publishing.
4. Placeholders to clear
For the client — confirm
0 of 6 completed
For the editorial team — verify